Eric Perakslis

Chief Scientific Officer, Datavant
When
7th-8th May 2018
Where
Boston, MA, USA
Boston Park Plaza
Global Engage is pleased to announce the 2018 Precision Medicine & Biomarkers Leaders Summit USA taking place on May 7-8th in Boston, MA. The event is part of our highly successful Drug Discovery Series which includes conferences on Biologics, Medicinal Chemistry, NASH, Pharmaceutical R&D IT and the Human Microbiome amongst others. It is also the sister meeting of the European Precision Medicine Summit which has run successfully since 2013.
This expanding series attracts the leading authorities worldwide working in companion diagnostics, biomarkers, immuno-oncology, liquid biopsies, AI and other facets of precision medicine. It has been praised for its stimulating, interactive and engaging environment where it brings together a multi-disciplined community of researchers, leaders and innovators whose aim is to develop groundbreaking and impactful treatments for patients.
Click here for the full speaker list.
Precision Medicine Integration Manager, Personalized Health, Inova Center for Personalized Health
Chief Scientific Officer, SeraCare Life Sciences, Massachusetts
Founder, President & CEO, Alzheon
President & CEO, AdMeTech Foundation
Senior Vice President & Chief Medical Officer, EMD Serono
Manager, Clinical Data Analytics & Reporting, Jackson Laboratory for Genomic Medicine
Supervisor, Clinical Genomic Testing, Jackson Laboratory for Genomic Medicine
CEO, Ischemia Care
Senior advisor to various companies in the Artificial Intelligence and Biotechnology sectors
Vice President, Head, Regeneron Genetics Center – Regeneron Pharmaceuticals, Inc.
Global VP of Biomarker Development & Medical Director, Almac Diagnostics
CEO, HeritX
Director, Cachexia Discovery & Therapeutic Development, Broad Institute of MIT & Harvard
CEO, iSpecimen
Global Regulatory Lead, Foundation Medicine
Director of Business Development, Abcam
Head of Companion Diagnostics and Biomarkers, Merrimack Pharmaceuticals
Senior Director of Diagnostic Development ArcherDX, INC
Associate Director of Translational Medicine, Agenus
Vice President, Head Early Development, Strategy and Innovation Novartis
Senior Director, Head of Clinical Biomarkers, Vertex
Director, Global Regulatory Affairs – Precision Medicine, Novartis
CEO RowAnalytics/precisionlife
Senior Vice President, Business and Corporate Development, Adaptive Biotechnologies Corp.
Vice President, The Green Valley Research Institute, Head of Bioinformatics, the Green Valley Pharmaceutical Company, Shanghai, China
Vice President, Biomarker Sciences, Gilead Sciences, Inc
Vice President, Translational Science, Oncology, AstraZeneca
Chief Scientific Officer, Datavant
President Lilly Research Labs (Head of R&D), Eli Lilly
Vice President, Head of Translational Biomarkers, Merck Research Laboratories
Senior Director, AI & Machine Learning, Berg
Vice President, Global Medical Affairs, Celgene
Chief Technology Officer, NuMedii, Inc
Director, Oncology Biomarker Research, Clinical Research, Oncology Business Group, Eisai
President and Founder, Acrivon Therapeutics
Head Business Development Biopharma, OncoDNA
Co-founder and CEO, Data4Cure
Senior Director of Translational Research, Incyte
Associate Director, Translational Immunology, Immunology Discovery, Abbvie
Co-Founder & Chief Scientific Officer, Rafael Pharma
Consultant, Genome Interpretation and Bioinformatics, Human Longevity, Inc.
Associate Director, Oncology Biologics, Discovery, Abbvie
Personalized Medicine Staff, Office of In Vitro Diagnostics and Radiological Health, FDA
Co-founder and CEO, Pangea Diagnostics
Vice President, Head of Translational Medicine and Biomarker Strategy Aevi Genomic Medicine, USA
VP Sales, Marketing and BD, Intomics
Associate Director, Translational Medicine and Diagnostics, Puma Biotechnology, Inc
Director, Global Regulatory Strategy – Oncology, Eisai
Senior Vice President, Immuno-oncology, Genocea BiosciencesSenior Vice President, Immuno-oncology, Genocea Biosciences
Vice President, LEO Science & Tech Hub
Founding Director, New Medicines Partners
Precision Medicine Integration Manager, Personalized Health, Inova Center for Personalized Health
Chief Scientific Officer, SeraCare Life Sciences, Massachusetts
Founder, President & CEO, Alzheon
President & CEO, AdMeTech Foundation
Senior Vice President & Chief Medical Officer, EMD Serono
Manager, Clinical Data Analytics & Reporting, Jackson Laboratory for Genomic Medicine
Supervisor, Clinical Genomic Testing, Jackson Laboratory for Genomic Medicine
CEO, Ischemia Care
Senior advisor to various companies in the Artificial Intelligence and Biotechnology sectors
Vice President, Head, Regeneron Genetics Center – Regeneron Pharmaceuticals, Inc.
Global VP of Biomarker Development & Medical Director, Almac Diagnostics
CEO, HeritX
Director, Cachexia Discovery & Therapeutic Development, Broad Institute of MIT & Harvard
CEO, iSpecimen
Global Regulatory Lead, Foundation Medicine
Director of Business Development, Abcam
Head of Companion Diagnostics and Biomarkers, Merrimack Pharmaceuticals
Senior Director of Diagnostic Development ArcherDX, INC
Associate Director of Translational Medicine, Agenus
Vice President, Head Early Development, Strategy and Innovation Novartis
Senior Director, Head of Clinical Biomarkers, Vertex
Director, Global Regulatory Affairs – Precision Medicine, Novartis
CEO RowAnalytics/precisionlife
Senior Vice President, Business and Corporate Development, Adaptive Biotechnologies Corp.
Vice President, The Green Valley Research Institute, Head of Bioinformatics, the Green Valley Pharmaceutical Company, Shanghai, China
Vice President, Biomarker Sciences, Gilead Sciences, Inc
Vice President, Translational Science, Oncology, AstraZeneca
Chief Scientific Officer, Datavant
President Lilly Research Labs (Head of R&D), Eli Lilly
Vice President, Head of Translational Biomarkers, Merck Research Laboratories
Senior Director, AI & Machine Learning, Berg
Vice President, Global Medical Affairs, Celgene
Chief Technology Officer, NuMedii, Inc
Director, Oncology Biomarker Research, Clinical Research, Oncology Business Group, Eisai
President and Founder, Acrivon Therapeutics
Head Business Development Biopharma, OncoDNA
Co-founder and CEO, Data4Cure
Senior Director of Translational Research, Incyte
Associate Director, Translational Immunology, Immunology Discovery, Abbvie
Co-Founder & Chief Scientific Officer, Rafael Pharma
Consultant, Genome Interpretation and Bioinformatics, Human Longevity, Inc.
Associate Director, Oncology Biologics, Discovery, Abbvie
Personalized Medicine Staff, Office of In Vitro Diagnostics and Radiological Health, FDA
Co-founder and CEO, Pangea Diagnostics
Vice President, Head of Translational Medicine and Biomarker Strategy Aevi Genomic Medicine, USA
VP Sales, Marketing and BD, Intomics
Associate Director, Translational Medicine and Diagnostics, Puma Biotechnology, Inc
Director, Global Regulatory Strategy – Oncology, Eisai
Senior Vice President, Immuno-oncology, Genocea BiosciencesSenior Vice President, Immuno-oncology, Genocea Biosciences
Vice President, LEO Science & Tech Hub
Founding Director, New Medicines Partners
Presentation by Lon Cardon, Senior Vice President, Target Sciences, GlaxoSmithKline
Presentation by Akintunde Bello, Executive Director, Bristol-Myers Squibb
Presentation by Christophe Le Tourneau, Head of Early Phase Clinical Trials & Head and Neck Cancer Groups, Institut Curie
This two-day summit features over 48 contributions. Four interactive tracks will explore strategies and technologies to deliver precision medicine, biomarkers in clinical & translational development, companion diagnostic partnerships & development and Immuno-Oncology.
To help you gain the most from your attendance, the program includes six extended panel discussions to go deeper into key issues such as Artificial Intelligence and biomarker patient selection strategies. The panel discussions are structured to encourage your participation with time for questions to be put to the panellists.
In addition, there are seven roundtable discussions covering precision medicine clinical trials, new directions in immuno-oncology, advancing liquid biopsy to the clinic and harnessing AI to name just four. These more intimate sessions are led by an expert with the aim of fostering dialogue between all the participants.
Download the AgendaGet news about new precision medicine and biomarker developments research and applications direct to your inbox.
2018 Sponsors
Boston Park Plaza
50 Park Plaza at Arlington Street,
Boston, MA 02116-3912
Boston Park Plaza is so much more than a hotel. We are a Boston icon
that is as much a part of the city’s heritage as the Boston Tea Party and
the annual Head of the Charles Regatta. We offer an experience that is
truly one-of-a-kind, a place where you can enjoy a richly textured and
profoundly memorable taste of the real Boston.
Following a landmark renovation, our hotel, Boston Park Plaza offers
guests all the charisma and deeply individual charm of a historic hotel
with the effortless comforts of a new one. Once again a destination unto
itself, our hotel offers incomparable proximity to everything that makes
Boston a treasured destination. We are one of the most sought-after
hotels near Boston Common and enjoy an ideal location among the
hotels in downtown Boston, just steps away from the Public Garden,
Theater District and many of the city’s most popular historical sites.
When you’re looking for the best hotel, Boston Park Plaza provides an
unrivaled legacy of service. When Boston Park Plaza opened in 1927, it
redefined a standard of hospitality that guests came to expect. With our
history of innovation and continued dedication to our guests, we are
proud to be recognized as Boston’s Most Beloved
3 for the price of 2 offer
Discount applied automatically when registering 3 places at once.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
All conference sessions
Lunches and refreshments
Access to exhibition room
All networking forums
Conference workbook
e-documentation pack
Option 1 – Please phone USA +1 646 844 7390 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
$1,499.00
Standard registration for those not in the categories below
$599.00
Click to select
$1,899.00
This fee applies to organisations offering services and/or business & technology solutions and also to business consultants.
Intomics was founded by leading scientists within the fields of bioinformatics and systems biology to accelerate and improve drug discovery and development through optimized usage of biomedical data.Based on vast experience with a broad range of data types and a high success rate with disease related research, the founders were convinced that the pharmaceutical industry could benefit from their pioneering research. Our focus has always been on establishing close collaborations that fully exploit the synergy between our clients’ specific disease knowledge and our unique solutions.
×Abcam is a global leader in antibody discovery and development. We specialize in producing precise biological binders to address important and novel targets in critical biological pathways. Abcam partners with pharmaceutical and diagnostic companies to develop recombinant antibodies as key reagents in drug discovery, diagnostics and therapeutics. With expertise and industry knowledge, we offer a tailored solution for end-to-end, full-cycle support of antibody commercialization: from antibody to validation support, pre-clinical selection, licensing, and market access.
×OncoDNA, The Cancer Theranostic Company, is the European leading oncology company providing solutions for cancer treatments, at the same time contributing to the knowledge applied to the fight against cancer. OncoDNA’s team is fully dedicated to help oncologists worldwide developing services to enable better treatment choices and treatment efficacy monitoring. The reports and the results are displayed in a dynamic way through the web platform OncoSHARE in order to allow an easy and fast reading.
×iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The company has developed the iSpecimen Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them.
×Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T cell and B cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.
https://www.adaptivebiotech.com/
×We’re a precision medicine company with patented A.I. deep semantic technology for search, discovery and decision support. We specialize in “multi-omics hyper-combinatorial high-dimensional” analysis which means we analyze all forms of data (genomic, phenotypic, lifestyle, clinical, imaging, epigenetic, etc.), in combination to model the way disease actually works, on massive data sets to identify biomarkers, stratify patients, predict disease risk and treatment response, and more. Our technology scales from populations to personal. No supercomputer required.
×ArcherDX addresses the bottlenecks associated with using NGS in translational research by offering a robust platform for targeted sequencing applications. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and a powerful bioinformatics platform, ArcherDX technology dramatically enhances mutation identification and discovery.
×Trans-Hit Bio is the worldwide biospecimen access CRO with the most extensive collection capability for biospecimens and clinical samples through an unrivaled worldwide partnered-network of biorepositories and clinical sites, facilitating direct interactions between our customers and hospital-based-biobanks allowing the scientific-and medical expertise of academics to be drawn upon and leveraged.
×DATA4CURE’s Biomedical Intelligence® Cloud combines systems biology with an advanced semantic AI integration engine to turn big omics and clinical data into a continuously updated biomedical knowledge graph. By actively mining thousands of public and proprietary datasets and millions of biomedical publications this technology discovers genes, pathways and networks underlying disease and treatment response, merging diverse pieces of evidence to increase statistical power and facilitating continuous translation of data to knowledge. Leading pharmaceutical companies use the platform to search for new targets, repurpose drugs for new indications, identify disease subtypes and predictors of drug response and resistance.
×Almac Diagnostics is a precision medicine company, focused on the discovery, development and commercialisation of complex diagnostic tests. The company, based in Craigavon, UK and Durham, USA has been in existence for over 15 years. Our diagnostic experience spans oncology, immunology, CNS, and infective diseases. We offer clients a highly Customised CDx partnership approach with tailored solutions, utilising complex biology, to help you differentiate your drug in the marketplace.
https://www.almacgroup.com/diagnostics/
×Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximize return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Tony Couch
Telephone USA +1 646 844 7390 or
email sponsorship@globalengage.co.uk
AllSeq has created the world’s first true Sequencing Marketplace. Our NGS marketplace helps researchers pick the best provider for their needs (based on price, technology, turnaround time, etc). AllSeq also maintains the NGS Knowledge Bank, a neutral source of information on the various sequencing technologies, platforms and applications.
×American Pharmaceutical Review is a journal covering the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies.
×An STM journal publisher of online and print and open access journals, and related print/online book series, Bentham Science answers the informational needs of the pharmaceutical, biomedical and medical research community.
×Biocompare is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists.
×As a network organisation, BioM supports the Bavarian biotechnology and pharmaceutical industry in establishing new business contacts on behalf of the Bavarian Ministry of Economic Affairs. BioM offers comprehensive consulting and specialized programs especially for prospective company founders.
×BioPartner UK is the independent, accredited trade organisation that promotes international partnering for trade, investment and collaborations with UK life science enterprises.
×Genetic Engineering and Biotechnology News (GEN) is the largest circulated global biotechnology news publication. It focuses on Biobusiness, OMICS, Drug Discovery, Bioprocessing, and Translational Medicine.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made research.
×IJBHR addresses a broad range of original experimental and theoretical papers that deal with behavioural and healthcare concerns. It welcomes high-quality papers from scientists in academic and non-academic organisations as well as business and government worldwide. IJBHR is sponsored by the Business and Economics Society International and the Frontiers in Immunology Research Network.
×Functional informatics and personalised medicine in the new era of biomedical sciences and computational sciences are interactive disciplines that hold great promise for the advancement of cutting-edge research and development in biomedical informatics and pharmaceutical sciences. IJFIPM is dedicated to promoting the research, education and awareness of functional informatics and personalised medicine, and provides a common platform for the cross-fertilisation of ideas by bridging important and complementary disciplines into an interactive and attractive forum.
×Medical Sciences (http://www.mdpi.com/journal/medsci) is an international open access scientific journal, recently indexed in PubMed. This free-of-charge journal provides a platform for advances in basic, translational and clinical research. Researchers in academic and clinical settings as well as health professionals are encouraged to publish their original research, review articles and short communications about molecular and cellular processes in disease of any medical specialty. Manuscripts are peer-reviewed, a first decision is provided to authors 18 days after submission, and acceptance to publication is undertaken in 6 days (median values for papers published in this journal in 2017).
×Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
×In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×Pink Medico – Medical and Healthcare Magazine (Print & Digital Version). We educate and empower consumers through our portal with latest news and trends, updates of medical and healthcare providers, pharma companies, new research and technologies, Medical Tourism… We are a revolutionary medical and healthcare aggregator that supports complete healthcare and allied services. We create a 360-degree approach towards quality healthcare service and ensure a wide range of people understand and avail healthcare easily. We are also NABH (National Accreditation Board for Hospitals and Healthcare Providers, India) Accredited Medical Tourism Facilitator.
×The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and speciality chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.
Since 2014 the SBA is consortia member of Ecobiofor, an FP7 project with researcher organizations, biotech and paint associations and pains SME’s developing bio-based solvents using green chemistry and biotechnology.
×Technology Networks is an internationally recognised, online publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas
×The Pathologist is a must-read source for all specialists operating in the field, including molecular diagnostics, biochemistry, histology, microbiology, immunology, hematology, and cytology. Covering all aspects of the field, from research and technological breakthroughs to laboratory management and regulatory issues, The Pathologist gives a voice to the profession that is at the heart of delivering exceptional quality healthcare.
×We are a creative events marketing firm that will assist you in ensuring that your endeavours are successful. With a combination of utilizing our robust experience in the industry, professional methods, immense enthusiasm and technology, we are assisting in delivering the best service possible to our esteemed clients.
Our aim is to bring all the stakeholders in conference industry in a singular platform to help them all to get their desired outcomes. Being a boutique firm, we offer flexibility and can provide a more bespoke service to furnish your company requirements more efficiently. Our company reaches are global and our marketing leads expand over 13 promising industries ensuring the coverage of the largest target audience. Please explore the rest of our website and contact us directly for further information.
×Call us on USA +1 646 844 7390
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.
Sign up to receive updates, news and speaker resources